PL3629026T3 - Środki modulujące ból przewodu pokarmowego - Google Patents

Środki modulujące ból przewodu pokarmowego

Info

Publication number
PL3629026T3
PL3629026T3 PL19207905T PL19207905T PL3629026T3 PL 3629026 T3 PL3629026 T3 PL 3629026T3 PL 19207905 T PL19207905 T PL 19207905T PL 19207905 T PL19207905 T PL 19207905T PL 3629026 T3 PL3629026 T3 PL 3629026T3
Authority
PL
Poland
Prior art keywords
gastrointestinal pain
agents modulating
modulating gastrointestinal
agents
pain
Prior art date
Application number
PL19207905T
Other languages
English (en)
Inventor
Eamonn CONOLLY
Wolfgang Kunze
John Bienenstock
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of PL3629026T3 publication Critical patent/PL3629026T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19207905T 2014-01-23 2015-01-23 Środki modulujące ból przewodu pokarmowego PL3629026T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1450065 2014-01-23
SE1450813 2014-07-01
EP19207905.1A EP3629026B1 (en) 2014-01-23 2015-01-23 Agents modulating gastrointestinal pain
PCT/SE2015/050064 WO2015112083A1 (en) 2014-01-23 2015-01-23 Selection of agents modulating gastrointestinal pain
EP15703840.7A EP3097423B1 (en) 2014-01-23 2015-01-23 Selection of agents modulating gastrointestinal pain

Publications (1)

Publication Number Publication Date
PL3629026T3 true PL3629026T3 (pl) 2021-08-02

Family

ID=52465569

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19207905T PL3629026T3 (pl) 2014-01-23 2015-01-23 Środki modulujące ból przewodu pokarmowego

Country Status (19)

Country Link
US (3) US20160334391A1 (pl)
EP (2) EP3097423B1 (pl)
JP (1) JP6635925B2 (pl)
KR (1) KR102154382B1 (pl)
CN (1) CN106164674B (pl)
AU (1) AU2015209763B2 (pl)
BR (1) BR122023013786B1 (pl)
CA (1) CA2936560C (pl)
CL (1) CL2016001878A1 (pl)
DK (1) DK3629026T3 (pl)
ES (2) ES2874479T3 (pl)
IL (1) IL246563B (pl)
MX (1) MX369105B (pl)
NZ (1) NZ721882A (pl)
PL (1) PL3629026T3 (pl)
RU (1) RU2692671C2 (pl)
SG (1) SG11201605378TA (pl)
UA (1) UA120846C2 (pl)
WO (1) WO2015112083A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
US11376287B2 (en) 2016-10-20 2022-07-05 Biofermin Pharmaceutical Co., Ltd. Agent acting on transcellular ion transporter in intestinal tract, agent for activating chloride channel, agent for preventing or treating renal disease, or agent for promoting defecation
PL3701051T3 (pl) * 2018-07-24 2022-10-31 Biogaia Ab Wybór i zastosowanie bakterii wspomagających melatoninę w celu zmniejszenia kolki niemowlęcej
US20230057324A1 (en) * 2018-07-24 2023-02-23 Biogaia Ab Therapeutic Methods Using Bacterial Strains Which are Capable of Increasing Adenosine Levels
CN111484982A (zh) * 2020-05-14 2020-08-04 西南民族大学 一种人结直肠腺癌细胞trpv1基因敲除细胞株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289984B1 (it) 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
CN101194036A (zh) * 2005-04-01 2008-06-04 南伊利诺斯大学董事会 金属间结合金刚石复合材料及该复合材料件的形成方法
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
US20080051454A1 (en) 2006-04-21 2008-02-28 The Board Of Trustees Operating Michigan State University Compositions and methods for transient receptor potential vanilloid (TRPV) channel mediated treatments
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
WO2008090434A1 (en) 2007-01-25 2008-07-31 Pfizer Japan Inc. Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
EP2307042B1 (en) * 2008-06-25 2014-03-26 H. Lundbeck A/S Modulation of the trpv : vps10p-domain receptor system for the treatment of pain
KR101091810B1 (ko) 2009-09-11 2011-12-12 고려대학교 산학협력단 신규 활성제를 이용한 trpv1 활성화 방법
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
EP2753319B1 (en) * 2011-09-09 2018-04-11 Vizuri Health Sciences LLC A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof
JPWO2013141202A1 (ja) 2012-03-21 2015-08-03 独立行政法人国立精神・神経医療研究センター 筋増加剤、及び筋増加物質のスクリーニング方法

Also Published As

Publication number Publication date
NZ721882A (en) 2019-02-22
JP2017507651A (ja) 2017-03-23
KR102154382B1 (ko) 2020-09-10
MX369105B (es) 2019-10-29
RU2692671C2 (ru) 2019-06-26
IL246563A0 (en) 2016-08-31
AU2015209763A1 (en) 2016-07-21
JP6635925B2 (ja) 2020-01-29
ES2874479T3 (es) 2021-11-05
RU2016134215A3 (pl) 2018-09-28
CA2936560C (en) 2021-06-01
US20180259503A1 (en) 2018-09-13
BR122023013786B1 (pt) 2023-12-12
CA2936560A1 (en) 2015-07-30
SG11201605378TA (en) 2016-08-30
BR112016016969A2 (pt) 2020-09-24
RU2016134215A (ru) 2018-03-01
UA120846C2 (uk) 2020-02-25
MX2016009613A (es) 2016-11-08
EP3097423B1 (en) 2019-12-04
CL2016001878A1 (es) 2017-10-20
EP3629026B1 (en) 2021-02-24
EP3629026A1 (en) 2020-04-01
ES2767060T3 (es) 2020-06-16
AU2015209763B2 (en) 2020-12-24
EP3097423A1 (en) 2016-11-30
CN106164674A (zh) 2016-11-23
CN106164674B (zh) 2018-10-09
IL246563B (en) 2019-11-28
US10656141B2 (en) 2020-05-19
WO2015112083A1 (en) 2015-07-30
US20160334391A1 (en) 2016-11-17
US20200225214A1 (en) 2020-07-16
US11371985B2 (en) 2022-06-28
KR20160111992A (ko) 2016-09-27
DK3629026T3 (da) 2021-05-17

Similar Documents

Publication Publication Date Title
IL248937A0 (en) Biphasic cosmetics
PL3132034T3 (pl) Środek terapeutyczny
SG11201608388TA (en) Applicator
GB201410816D0 (en) Therapeutic agents
EP3020328C0 (en) SKIN APPLICABLE MEDICAL DEVICE
GB201410216D0 (en) Therapeutic
GB201410817D0 (en) Therapeutic agents
GB201410815D0 (en) Therapeutic agents
IL246563B (en) Selection of substances that regulate pain in the digestive system
GB201416727D0 (en) Use
GB201416716D0 (en) Use
GB201510637D0 (en) Therapeutic
GB201403032D0 (en) Medical device
GB201411027D0 (en) Treatment
GB201407940D0 (en) Ambulatory devices
GB201408540D0 (en) Burstable pouch
GB201421879D0 (en) Therapeutic agents
GB201421715D0 (en) Therapeutic agents
GB201400215D0 (en) Modulators
GB201418508D0 (en) Therapeutic
GB201420534D0 (en) Use
GB201420535D0 (en) Use
GB201420365D0 (en) Use
GB201418424D0 (en) Applicator
GB201413719D0 (en) Therapeutic